Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society. 2013

Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
University of Birmingham Centre for Cardiovascular Sciences, Institute for Biomedical Research, Birmingham, UK. p.kirchhof@bham.ac.uk

UI MeSH Term Description Entries
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D003663 Decision Trees A graphic device used in decision analysis, series of decision options are represented as branches (hierarchical). Decision Tree,Tree, Decision,Trees, Decision
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D005582 Foundations Organizations established by endowments with provision for future maintenance. Foundation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations
D012955 Societies, Medical Societies whose membership is limited to physicians. Medical Societies,Medical Society,Society, Medical
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice

Related Publications

Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
March 2017, JAMA cardiology,
Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
December 2018, The Journal of innovations in cardiac rhythm management,
Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
January 2022, Cardiology,
Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
December 2020, The Canadian journal of cardiology,
Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
September 2022, Journal of the American College of Cardiology,
Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
September 2022, European heart journal,
Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
January 2011, The Canadian journal of cardiology,
Paulus Kirchhof, and Anne B Curtis, and Allan C Skanes, and Anne M Gillis, and L Samuel Wann, and A John Camm
November 2017, Circulation. Arrhythmia and electrophysiology,
Copied contents to your clipboard!